questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
NADH, NADPH oxidoreductases
NADH, NADPH oxidoreductases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "NADH, NADPH oxidoreductases : Questions médicales les plus fréquentes",
"headline": "NADH, NADPH oxidoreductases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les NADH, NADPH oxidoreductases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "NADH, NADPH oxidoreductases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases",
"url": "https://questionsmedicales.fr/mesh/D010088",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D010088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cytochrome reductases",
"alternateName": "Cytochrome Reductases",
"url": "https://questionsmedicales.fr/mesh/D003579",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome reductases",
"code": {
"@type": "MedicalCode",
"code": "D003579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.191"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADPH-ferrihemoprotéine reductase",
"alternateName": "NADPH-Ferrihemoprotein Reductase",
"url": "https://questionsmedicales.fr/mesh/D009251",
"about": {
"@type": "MedicalCondition",
"name": "NADPH-ferrihemoprotéine reductase",
"code": {
"@type": "MedicalCode",
"code": "D009251",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.191.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "NADH tetrazolium reductase",
"alternateName": "NADH Tetrazolium Reductase",
"url": "https://questionsmedicales.fr/mesh/D009246",
"about": {
"@type": "MedicalCondition",
"name": "NADH tetrazolium reductase",
"code": {
"@type": "MedicalCode",
"code": "D009246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.530"
}
}
},
{
"@type": "MedicalWebPage",
"name": "NADP transhydrogenases",
"alternateName": "NADP Transhydrogenases",
"url": "https://questionsmedicales.fr/mesh/D009250",
"about": {
"@type": "MedicalCondition",
"name": "NADP transhydrogenases",
"code": {
"@type": "MedicalCode",
"code": "D009250",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.540"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADP transhydrogenase, AB-specific",
"alternateName": "NADP Transhydrogenase, AB-Specific",
"url": "https://questionsmedicales.fr/mesh/D061087",
"about": {
"@type": "MedicalCondition",
"name": "NADP transhydrogenase, AB-specific",
"code": {
"@type": "MedicalCode",
"code": "D061087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.540.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "NADPH dehydrogenase",
"alternateName": "NADPH Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D009252",
"about": {
"@type": "MedicalCondition",
"name": "NADPH dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D009252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Quinone reductases",
"alternateName": "Quinone Reductases",
"url": "https://questionsmedicales.fr/mesh/D011808",
"about": {
"@type": "MedicalCondition",
"name": "Quinone reductases",
"code": {
"@type": "MedicalCode",
"code": "D011808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADPH dehydrogenase (quinone)",
"alternateName": "NAD(P)H Dehydrogenase (Quinone)",
"url": "https://questionsmedicales.fr/mesh/D016660",
"about": {
"@type": "MedicalCondition",
"name": "NADPH dehydrogenase (quinone)",
"code": {
"@type": "MedicalCode",
"code": "D016660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.800.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "NADH, NADPH oxidoreductases",
"alternateName": "NADH, NADPH Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D009247",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fei-Long Li",
"url": "https://questionsmedicales.fr/author/Fei-Long%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Ye-Wang Zhang",
"url": "https://questionsmedicales.fr/author/Ye-Wang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China; College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou 535011, People's Republic of China. Electronic address: zhangyewang@ujs.edu.cn."
}
},
{
"@type": "Person",
"name": "Chuanwu Xia",
"url": "https://questionsmedicales.fr/author/Chuanwu%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA."
}
},
{
"@type": "Person",
"name": "Anna L Shen",
"url": "https://questionsmedicales.fr/author/Anna%20L%20Shen",
"affiliation": {
"@type": "Organization",
"name": "McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53706, USA."
}
},
{
"@type": "Person",
"name": "Jung-Ja P Kim",
"url": "https://questionsmedicales.fr/author/Jung-Ja%20P%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. Electronic address: jjkim@mcw.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A specific upregulated long noncoding RNA in colorectal cancer promotes cancer progression.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35617032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1172/jci.insight.158855"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel long noncoding RNA CIL1 enhances cold stress tolerance in Arabidopsis.",
"datePublished": "2022-07-02",
"url": "https://questionsmedicales.fr/article/35788028",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.plantsci.2022.111370"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.",
"datePublished": "2023-01-30",
"url": "https://questionsmedicales.fr/article/36793272",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.938102"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long Intergenic Noncoding RNA MIAT as a Regulator of Human Th17 Cell Differentiation.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35784351",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.856762"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Long Noncoding RNA LINC00958 Is Induced in Psoriasis Epidermis and Modulates Epidermal Proliferation.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36641130",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jid.2022.12.011"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "NADH, NADPH oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D009247"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : NADH, NADPH oxidoreductases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur NADH, NADPH oxidoreductases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur NADH, NADPH oxidoreductases",
"description": "Comment diagnostiquer une déficience en NADH oxydoréductases ?\nQuels tests sanguins sont utiles pour évaluer NADPH ?\nQuels symptômes indiquent un problème avec ces enzymes ?\nLes tests d'activité enzymatique sont-ils fiables ?\nPeut-on détecter des anomalies génétiques liées à ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=RNA,+Long+Noncoding&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur NADH, NADPH oxidoreductases",
"description": "Quels sont les symptômes d'une carence en NADH ?\nComment se manifeste une déficience en NADPH ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nDes symptômes digestifs peuvent-ils apparaître ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=RNA,+Long+Noncoding&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur NADH, NADPH oxidoreductases",
"description": "Comment prévenir les déficiences en NADH ?\nY a-t-il des habitudes de vie à adopter ?\nLes bilans de santé réguliers sont-ils utiles ?\nLes vaccinations peuvent-elles jouer un rôle ?\nL'éducation nutritionnelle est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=RNA,+Long+Noncoding&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur NADH, NADPH oxidoreductases",
"description": "Quels traitements existent pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à réguler ces enzymes ?\nY a-t-il des traitements naturels recommandés ?\nLes transfusions sanguines sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=RNA,+Long+Noncoding&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur NADH, NADPH oxidoreductases",
"description": "Quelles complications peuvent survenir avec une déficience en NADH ?\nLes infections sont-elles une complication fréquente ?\nY a-t-il des risques de maladies chroniques ?\nLes complications cardiovasculaires sont-elles possibles ?\nDes complications hématologiques peuvent-elles survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=RNA,+Long+Noncoding&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur NADH, NADPH oxidoreductases",
"description": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes maladies génétiques sont-elles un facteur ?\nLe stress oxydatif joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=RNA,+Long+Noncoding&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en NADH oxydoréductases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour évaluer NADPH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages de NADPH et d'autres coenzymes dans le sang peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec ces enzymes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, faiblesse musculaire et troubles métaboliques peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Les tests d'activité enzymatique sont-ils fiables ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent utilisés pour évaluer la fonction des NADH et NADPH oxydoréductases."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies génétiques liées à ces enzymes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant ces enzymes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en NADH ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, troubles cognitifs et faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une déficience en NADPH ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des infections fréquentes et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en cas de dysfonctionnement enzymatique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général."
}
},
{
"@type": "Question",
"name": "Des symptômes digestifs peuvent-ils apparaître ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles digestifs peuvent être liés à des anomalies dans le métabolisme énergétique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déficiences en NADH ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en nutriments essentiels peut aider à prévenir ces déficiences."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes de vie à adopter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain incluant exercice et gestion du stress est recommandé."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter précocement des anomalies enzymatiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles jouer un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les déficiences."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'importance des nutriments peut aider à prévenir les carences."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée pour traiter certaines déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler ces enzymes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent aider à moduler l'activité des NADH et NADPH oxydoréductases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antioxydants et des nutriments peuvent soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, des transfusions peuvent être nécessaires pour corriger des déficiences."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en NADH ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des déficiences enzymatiques sont plus susceptibles aux infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déficiences peuvent augmenter le risque de maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles métaboliques peuvent entraîner des complications cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Des complications hématologiques peuvent-elles survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans le métabolisme peuvent entraîner des complications hématologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et une mauvaise nutrition."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines déficiences peuvent être plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques prédisposent aux déficiences en NADH et NADPH."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut aggraver les déficiences enzymatiques et leurs effets."
}
}
]
}
]
}
Long noncoding RNA (lncRNA) plays a crucial role in the pathogenesis of various diseases, including colorectal cancer (CRC). The gene mutations of adenomatous polyposis coli (APC) were found in most p...
With the intensification of global warming, extreme weather events have occurred more frequently, among which cold stress has become one of the major environmental factors that restrict global crop yi...
Hepatocellular carcinoma (HCC) is one of the most frequent malignancies. Alpha-fetoprotein (AFP) has some limitations in diagnosing early HCC. Recently, long noncoding RNAs (lncRNAs) showed great pote...
Quantitative real-time PCR was adopted to detect lnc-MyD88 expression in plasma samples of 98 HCC patients, 52 liver cirrhosis (LC) patients, and 105 healthy people. The correlation between lnc-MyD88 ...
Lnc-MyD88 was highly expressed in plasma samples of HCC and hepatitis B virus (HBV)-associated HCC patients. Lnc-MyD88 had better diagnostic value than AFP in HCC patients using healthy people or LC p...
The high expression of plasma lnc-MyD88 in HCC is distinct and could be utilized as a promising diagnostic biomarker. Lnc-MyD88 had great diagnostic value for HBV-associated HCC and AFP-negative HCC, ...
T helper 17 (Th17) cells protect against fungal and bacterial infections and are implicated in autoimmunity. Several long intergenic noncoding RNAs (lincRNA) are induced during Th17 differentiation, h...
Psoriasis is a common, immune-mediated skin disease characterized by epidermal hyperproliferation and chronic skin inflammation. Long noncoding RNAs are >200 nucleotide-long transcripts that possess i...
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disease of hematopoietic stem cells (HSCs). Long noncoding RNAs (lncRNAs) perform a wide range of biological functions, including the regulat...
Long non-coding RNAs (lncRNAs) present pivotal roles in cancer tumorigenesis and progression. Recently, nuclear paraspeckle assembly transcript 1 (NEAT1) as a lncRNA has been shown to mediate cell pro...
Neurodevelopmental syndromes due to copy number variation are well-known clinical entities. While the numerical variation of gene-harboring regions has been widely investigated at both molecular and c...
The aim of the current study is to evaluate the possible correlation between the single-nucleotide polymorphisms (SNP) of HOX transcript antisense intergenic RNA (HOTAIR) and the clinical characterist...
Human diseases are multifactorial processes mainly driven by the intricate interactions of genetic and environmental factors. Long noncoding RNAs (lncRNAs) represent a type of non-coding RNAs with mor...